Clinical utility of whole-genome sequencing in precision oncology

R Rosenquist, E Cuppen, R Buettner, C Caldas… - Seminars in Cancer …, 2022 - Elsevier
Precision diagnostics is one of the two pillars of precision medicine. Sequencing efforts in
the past decade have firmly established cancer as a primarily genetically driven disease …

Breast cancer heterogeneity and response to novel therapeutics

M Baliu-Piqué, A Pandiella, A Ocana - Cancers, 2020 - mdpi.com
Simple Summary Breast cancer is a heterogeneous disease that is driven by genetic,
epigenetic and phenotypic modifications and is also affected by the microenvironment and …

Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors

HK Patel, N Tao, KM Lee, M Huerta, H Arlt… - Breast Cancer …, 2019 - Springer
Background Addition of CDK4/6 inhibitors (CDK4/6i) to endocrine therapy significantly
increased progression-free survival, leading to their approval and incorporation into the …

Clinical genetics in breast cancer

KW Ntowe, MS Lee, JK Plichta - Journal of Surgical Oncology, 2024 - Wiley Online Library
As genetic testing becomes increasingly more accessible and more applicable with a
broader range of clinical implications, it may also become more challenging for breast …

Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer

G El Hachem, A Gombos, A Awada - F1000Research, 2019 - pmc.ncbi.nlm.nih.gov
Breast cancer is a global health issue. For decades, breast cancer was classified into many
histological subtypes on the basis of microscopic and immunohistochemical evaluation. The …

Characterization of multicellular breast tumor spheroids using image data-driven biophysical mathematical modeling

HJ Bowers, EE Fannin, A Thomas, JA Weis - Scientific reports, 2020 - nature.com
Multicellular tumor spheroid (MCTS) systems provide an in vitro cell culture model system
which mimics many of the complexities of an in vivo solid tumor and tumor …

[HTML][HTML] Breast Cancer Heterogeneity and Its Implication in Precision Therapy

F Candanedo-Gonzalez, AL Remirez-Castellanos… - 2025 - intechopen.com
Breast cancer (BC) is the most common cancer among women worldwide, with a
progressive increase in its incidence. It is the second leading cause of cancer-related death …

Development of an Image-Based Mathematical Modeling Tool for Multi-Scale Characterization of Breast Cancer Response to Neoadjuvant Therapy

HJ Bowers - 2022 - search.proquest.com
Breast cancer therapeutic regimens are currently administered in a structured and pre-
determined manner with drug and dosing strategies determined based on broad molecular …